0.78

15.22% -0.14

Pre-market: .86 0.08 +10.26%

Mink Therapeutics Inc (INKT)

Overview News Price History Financials Discussions Forecast

Mink Therapeutics Inc stock is traded at $0.78, with a volume of 250.45K. It is down -15.22% in the last 24 hours and up +14.71% over the past month. MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.

Previous Close:

$0.92

Open:

$0.881

24h Volume:

250.45K

Relative Volume:

2.73

Market Cap:

$30.91M

Revenue:

Net Income/Loss:

$-24.77M

P/E Ratio:

-1.0685

EPS:

-0.73

Net Cash Flow:

$-17.36M

1W Performance:

-22.77%

1M Performance:

+14.71%

6M Performance:

-12.42%

1Y Performance:

-22.77%

1-Day Range:

$0.738

$0.8894

1-Week Range:

$0.738

$1.04

52-Week Range:

$0.4632

$1.90

Mink Therapeutics Inc Stock (INKT) Company Profile

Name

Mink Therapeutics Inc

Sector

Healthcare (1233)

Industry

Biotechnology (3)

Phone

212-994-8250

Address

149 FIFTH AVENUE, NEW YORK

Employee

Twitter

Next Earnings Date

2024-08-13

Latest SEC Filings

INKT's Discussions on Twitter

Compare INKT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
INKT Mink Therapeutics Inc	0.78	30.91M	0	-24.77M	-17.36M	-0.73
VRTX Vertex Pharmaceuticals Inc	412.11	106.13B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	733.59	80.61B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	649.26	38.82B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	240.55	31.03B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	122.15	29.28B	3.30B	-501.07M	1.03B	-2.1146

Mink Therapeutics Inc Stock (INKT) Latest News

Jan 07, 2025

Kinaxis Inc. (TSE:KXS) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World

Jan 07, 2025

Nerdy, Inc. (NYSE:NRDY) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World

Jan 07, 2025

WEBTOON Entertainment Inc. (NASDAQ:WBTN) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Jan 07, 2025

Jan 03, 2025

Pre-market Movers: ONCO, COEP, NUVB, SPRC... - RTTNews

Jan 03, 2025

Jan 02, 2025

Stock Market Movers Today • Top Gainers & Losers - Benzinga

Jan 02, 2025

Dec 28, 2024

MML Investors Services LLC Acquires Shares of 12,147 Sabre Co. (NASDAQ:SABR) - Defense World

Dec 28, 2024

Dec 27, 2024

Carbon Streaming (OTCMKTS:OFSTF) Stock Price Up 5.5% – What’s Next? - Defense World

Dec 27, 2024

Dec 24, 2024

Best Penny Stocks for Today (Charts Updated Daily) - Benzinga

Dec 24, 2024

Dec 18, 2024

MiNK Therapeutics to Present iNKT Cell Therapy in Gastric Cancer at ASCO GI Annual Meeting - GlobeNewswire

Dec 18, 2024

Claire's Place Foundation Wraps up 2024 with Record-Breaking Events & Exciting Announcements for 2025 - The Manila Times

Dec 18, 2024

BiomX Inc. Regains Compliance with NYSE American Listing Standards - Defense World

Dec 18, 2024

Dec 17, 2024

Mink Therapeutics stock hits 52-week low at $0.56 amid market challenges - Investing.com Australia

Dec 17, 2024

Dec 16, 2024

Mink Ventures Commences Diamond Drill Program at Warren Nickel Copper Cobalt Project, Timmins, Ontario - Yahoo Finance

Dec 16, 2024

Dec 14, 2024

ATEX Resources (OTCMKTS:ECRTF) Stock Price Down 0.7% – Here’s Why - Defense World

Dec 14, 2024

Dec 09, 2024

Domo’s (DOMO) Market Outperform Rating Reiterated at JMP Securities - Defense World

Dec 09, 2024

Dec 05, 2024

Agenus Announces Strategic Realignment to Focus on Core Programs and Significantly Reduce Costs - Business Wire

Dec 05, 2024

Dec 04, 2024

FairJourney Biologics Appoints Dr. Marc van Dijk as Chief Scientific Officer of Antibody Discovery and Engineering - BioSpace

Dec 04, 2024

Dec 03, 2024

Arovella heads toward clinic with CAR-19-iNKT cells - BioWorld Online

Dec 03, 2024

Nov 28, 2024

Comparing MiNK Therapeutics (NASDAQ:INKT) & Acumen Pharmaceuticals (NASDAQ:ABOS) - Defense World

Nov 28, 2024

Nov 27, 2024

Agenus Secures $22 Million Mortgage and Announces Strategic Operational Realignment - Business Wire

Nov 27, 2024

Nov 22, 2024

Geenex Developed Mink Solar Project Approved by Ohio Power Siting Board - Yahoo Finance

Nov 22, 2024

Analyzing MiNK Therapeutics (NASDAQ:INKT) & Replimune Group (NASDAQ:REPL) - Defense World

Nov 22, 2024

Comparing Fractyl Health (GUTS) and Its Peers - Defense World

Nov 22, 2024

Nov 19, 2024

MiNK Therapeutics (NASDAQ:INKT) Given New $4.00 Price Target at Robert W. Baird - Defense World

Nov 19, 2024

Nov 17, 2024

Midwest Energy Emissions Becomes Birchtech Corp. and Announces Equity Incentive Plan AmendmentsOn October 29, 2024, Birchtech Corp. (formerly Midwest Energy Emissions Corp.) filed a Form 8-K with the SEC, detailing recent corporate changes and u - Defense World

Nov 17, 2024

Bright Mountain Media, Inc. Enters into Executive Employment Agreement with CEO Matthew DrinkwaterOn November 8, 2024, Bright Mountain Media, Inc. (OTCMKTS:BMTM) announced in an 8-K filing that they had entered into an Executive Employment Agr - Defense World

Nov 17, 2024

Nov 15, 2024

MiNK Therapeutics, Inc. (NASDAQ:INKT) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024

MiNK Therapeutics stock target cut, rating held amid pipeline updates By Investing.com - Investing.com UK

Nov 15, 2024